Revive Therapeutics Announces Successful Research Results for Psilocybin to Treat Traumatic Brain Injury and Filing of… Mar 19, 2021
Numinus Science Officer Sharan Sidhu: We Won’t Patent IP That Makes Psychedelics Inaccessible Mar 19, 2021